Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16571083rdf:typepubmed:Citationlld:pubmed
pubmed-article:16571083lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:16571083lifeskim:mentionsumls-concept:C0162508lld:lifeskim
pubmed-article:16571083lifeskim:mentionsumls-concept:C0040132lld:lifeskim
pubmed-article:16571083lifeskim:mentionsumls-concept:C0334227lld:lifeskim
pubmed-article:16571083lifeskim:mentionsumls-concept:C0031727lld:lifeskim
pubmed-article:16571083lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:16571083lifeskim:mentionsumls-concept:C0018270lld:lifeskim
pubmed-article:16571083lifeskim:mentionsumls-concept:C0205618lld:lifeskim
pubmed-article:16571083lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:16571083lifeskim:mentionsumls-concept:C0237477lld:lifeskim
pubmed-article:16571083lifeskim:mentionsumls-concept:C0205464lld:lifeskim
pubmed-article:16571083lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:16571083lifeskim:mentionsumls-concept:C0205088lld:lifeskim
pubmed-article:16571083pubmed:issue3lld:pubmed
pubmed-article:16571083pubmed:dateCreated2006-3-30lld:pubmed
pubmed-article:16571083pubmed:abstractTextThe high radioresistance of anaplastic thyroid cancer (ATC) and cultured ATC cells stipulates for the means of increasing their radiosensitivity. It has been shown that c-Jun NH(2)-terminal kinase (JNK) activation is one of the manifestations of radiation response in ATC cells.lld:pubmed
pubmed-article:16571083pubmed:languageenglld:pubmed
pubmed-article:16571083pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16571083pubmed:citationSubsetIMlld:pubmed
pubmed-article:16571083pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16571083pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16571083pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16571083pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16571083pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16571083pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16571083pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16571083pubmed:statusMEDLINElld:pubmed
pubmed-article:16571083pubmed:monthMarlld:pubmed
pubmed-article:16571083pubmed:issn1050-7256lld:pubmed
pubmed-article:16571083pubmed:authorpubmed-author:OhtsuruAkiraAlld:pubmed
pubmed-article:16571083pubmed:authorpubmed-author:YamashitaShun...lld:pubmed
pubmed-article:16571083pubmed:authorpubmed-author:NambaHiroyuki...lld:pubmed
pubmed-article:16571083pubmed:authorpubmed-author:MitsutakeNori...lld:pubmed
pubmed-article:16571083pubmed:authorpubmed-author:PodtchekoAlex...lld:pubmed
pubmed-article:16571083pubmed:authorpubmed-author:SaenkoVladimi...lld:pubmed
pubmed-article:16571083pubmed:authorpubmed-author:RogounovitchT...lld:pubmed
pubmed-article:16571083pubmed:authorpubmed-author:BulginDmitryDlld:pubmed
pubmed-article:16571083pubmed:authorpubmed-author:TakakuraShuSlld:pubmed
pubmed-article:16571083pubmed:authorpubmed-author:PalonaIrynaIlld:pubmed
pubmed-article:16571083pubmed:issnTypePrintlld:pubmed
pubmed-article:16571083pubmed:volume16lld:pubmed
pubmed-article:16571083pubmed:ownerNLMlld:pubmed
pubmed-article:16571083pubmed:authorsCompleteYlld:pubmed
pubmed-article:16571083pubmed:pagination217-24lld:pubmed
pubmed-article:16571083pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:16571083pubmed:meshHeadingpubmed-meshheading:16571083...lld:pubmed
pubmed-article:16571083pubmed:meshHeadingpubmed-meshheading:16571083...lld:pubmed
pubmed-article:16571083pubmed:meshHeadingpubmed-meshheading:16571083...lld:pubmed
pubmed-article:16571083pubmed:meshHeadingpubmed-meshheading:16571083...lld:pubmed
pubmed-article:16571083pubmed:meshHeadingpubmed-meshheading:16571083...lld:pubmed
pubmed-article:16571083pubmed:meshHeadingpubmed-meshheading:16571083...lld:pubmed
pubmed-article:16571083pubmed:meshHeadingpubmed-meshheading:16571083...lld:pubmed
pubmed-article:16571083pubmed:meshHeadingpubmed-meshheading:16571083...lld:pubmed
pubmed-article:16571083pubmed:meshHeadingpubmed-meshheading:16571083...lld:pubmed
pubmed-article:16571083pubmed:meshHeadingpubmed-meshheading:16571083...lld:pubmed
pubmed-article:16571083pubmed:meshHeadingpubmed-meshheading:16571083...lld:pubmed
pubmed-article:16571083pubmed:meshHeadingpubmed-meshheading:16571083...lld:pubmed
pubmed-article:16571083pubmed:meshHeadingpubmed-meshheading:16571083...lld:pubmed
pubmed-article:16571083pubmed:meshHeadingpubmed-meshheading:16571083...lld:pubmed
pubmed-article:16571083pubmed:year2006lld:pubmed
pubmed-article:16571083pubmed:articleTitleSelective pharmacologic inhibition of c-Jun NH2-terminal kinase radiosensitizes thyroid anaplastic cancer cell lines via induction of terminal growth arrest.lld:pubmed
pubmed-article:16571083pubmed:affiliationDepartment of Molecular Medicine, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan.lld:pubmed
pubmed-article:16571083pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16571083pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16571083lld:pubmed